Home LiteratureArticle Details
PMID: 33883344 Published · ppublish English Journal Article

Detection of novel and recurrent conjoined genes in non-Hodgkin B-cell lymphoma.

Journal of clinical and experimental hematopathology : JCEH ·Vol. 61 ·No. 2 ·2021-06-05 ·页码 71-77

Matsumoto Y, Tsukamoto T, Chinen Y, Shimura Y, Sasaki N, Nagoshi H, Sato R, Adachi H, Nakano M, Horiike S, Kuroda J, Taki T, Tashiro K, Taniwaki M

Abstract

For this study, we investigated comprehensive expression of conjoined genes (CGs) in non-Hodgkin B-cell lymphoma (B-NHL) cell line KPUM-UH1 by using paired-end RNA sequencing. Furthermore, we analyzed the expression of these transcripts in an additional 21 cell lines, 37 primary samples of various malignancies and peripheral blood mononuclear cells of four normal individuals. Seventeen CGs were detected in KPUM-UH1: CTBS-GNG5, SRP9-EPHX1, RMND5A-ANAPC, OTX1-EHBP1, ATF2-CHN1, PRKAA1-TTC33, LARP1-MRPL22, LOC105379697-BAK1, TIAM2-SCAF8, SPAG1-VPS13B, WBP1L-CNNM2, NARS2-GAB2, CTSC-RAB38, VAMP1-CD27-AS1, LRRC37A2-NSF, UBA2-WTIP and ZNF600-ZNF611. To our knowledge, 10 of these genes have not been previously reported. The various characteristics of the CGs included in- and out-of-frame fusions, chimeras involving non-coding RNA and transcript variants. A finding of note was that LARP1-MRPL2 was characterized as in-frame fusion and was recurrently expressed in B-NHL samples. In this study, variety of CGs was expressed both in malignant and normal cells, some of which might be specific to lymphoma.

Keywords
LARP1 MRPL2 Conjoined genes non-Hodgkin B-cell lymphoma
MeSH 主题词
Base Sequence Cell Line, Tumor Gene Dosage Humans Lymphoma, B-Cell/genetics Oncogene Fusion Oncogene Proteins, Fusion/genetics Sequence Analysis, RNA Tumor Cells, Cultured
化学物质
Oncogene Proteins, Fusion
作者与单位
共 14 位作者,点击展开单位 / ORCID
Matsumoto Yosuke
Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
Tsukamoto Taku
Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Chinen Yoshiaki
Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan. | Department of Hematology, Fukuchiyama City Hospital, Fukuchiyama, Japan.
Shimura Yuji
Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Sasaki Nana
Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
Nagoshi Hisao
Department of Hematology and Oncology, Hiroshima University, Hiroshima, Japan.
Sato Ryuichi
Department of Genomic Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Adachi Hiroko
Department of Genomic Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Nakano Masakazu
Department of Genomic Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Horiike Shigeo
Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Kuroda Junya
Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Taki Tomohiko
Department of Medical Technology, Kyorin University Faculty of Health Science, Tokyo, Japan.
Tashiro Kei
Department of Genomic Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Taniwaki Masafumi
Center for Molecular Diagnostics and Therapeutics, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Article Info
Journal
Journal of clinical and experimental hematopathology : JCEH
Abbr.
J Clin Exp Hematop
ISSN
1880-9952
Published
2021-06-05
电子出版
2021-00-20
页码
71-77
Language
English
Country/Region
Japan
NLM ID
101141257
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com